- Home
- SCPH
as 12-20-2024 3:42pm EST
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 274.7M | IPO Year: | 2017 |
| Target Price: | $15.00 | AVG Volume (30 days): | 544.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.96 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.08 - $6.71 | Next Earning Date: | 11-13-2024 |
| Revenue: | $30,278,000 | Revenue Growth: | 303.87% |
| Revenue Growth (this year): | 174.12% | Revenue Growth (next year): | 133.41% |
Latest scPharmaceuticals Inc. News
SCPH Breaking Stock News: Dive into SCPH Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
Earnings Update: scPharmaceuticals Inc. (NASDAQ:SCPH) Just Reported And Analysts Are Trimming Their Forecasts
Simply Wall St.
a month ago
scPharmaceuticals Third Quarter 2024 Earnings: Misses Expectations
GuruFocus.com
a month ago
scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
Zacks
a month ago
ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates
MT Newswires
a month ago
ScPharmaceuticals Q3 Loss Widens, Revenue Rises
GlobeNewswire
a month ago
scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update
Zacks
a month ago
TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock?
GlobeNewswire
2 months ago
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
Compare SCPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SCPH scPharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.